Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ashley L. Ward, MD
MacroGenics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Monash Health, Medical Oncology Department
Ruse, New South Wales, Australia
- Royal North Shore Hospital
Sydney, New South Wales, Australia
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Icon Cancer Centre Southport
Southport, Queensland, Australia
- Andrew Love Cancer Centre, Barwon Health
Geelong, Victoria, Australia
- Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Complex Oncology Center Ruse Ltd.
Dobrich, Bulgaria
- Mhat Serdica
Panagyurishte, Bulgaria
- Mbal Uni Hospital
Pleven, Bulgaria
- Coc Dobrich
Sofia, Bulgaria
- Mhat Nadezhda, Medical Oncology
Sofia, Bulgaria
- Umhat Georgi Stranski Medical Oncology Department
Sofia, Bulgaria
- Umhat Tsarisa Yoanna - Isul
Sofia, Bulgaria
- Bajcsy-Zsilinszky Korhaz
Budapest, Hungary
- Uzsoki Street Hospital
Budapest, Hungary
- Dept of Oncology, University of Debrecen
Debrecen, Hungary
- Dept of Oncology, Bekec County Hosp
Gyula, Hungary
- Dept of Oncology, Tolna County Hospital
Szekszárd, Hungary
- the Ewa Pilecka Department of Clinical Oncology
Bialystok, Poland
- Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
- I Clinics of Radiotherapy and Chemiotherapy; the Maria Sklodowska-Curie National Research Institute of Oncology
Gliwice, Poland
- Biokinetica
Józefów, Poland
- Clinics of Head and Neck Cancer, the Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
- Complejo Hospitalario Universitario de Badajoz
Badajoz, Spain
- Hospital Clínic de Barcelona
Barcelona, Spain
- Hospital Universitario Vall D'Hebrón
Barcelona, Spain
- Hospital Clínico San Carlos
Madrid, Spain
- Clinica Universidad de Navarra
Pamplona, Spain
- Hospital Universitario Virgen de la Macarena
Seville, Spain
- Communal Non-Profit Enterprise "city Clinical Hospital#4" of Dnipro City
Dnipro, Ukraine
- Communal Non-Profit Enterprise "regional Center of Oncology", Oncosurgical Department of Head and Neck
Kharkiv, Ukraine
- Communal Non-Profit Enterprise "regional Clinical Oncology Center of Kirovohrad Regional Council",
Kropyvnytskyi, Ukraine
- Kyiv City Clinical Oncological Centre
Kyiv, Ukraine
- Municipal Non-Profit Enterprise of Sumy Regional Council "sumy Regional Clinical Oncology Dispensary"
Sumy, Ukraine
- Communal Nonprofit Enterprise Podilsky Regional Center of Oncology
Vinnytsia, Ukraine
- University of Maryland, Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- University of North Carolina - Lineberger Cancer Center
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Mar 2021
- Primary completion
- 29 Jul 2022
- Completion
- 29 Jul 2022
- Last update posted
- 20 Dec 2023
- Registered enrollment
- 62
- Registry id
- NCT04634825
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.